Literature DB >> 21513781

Differential allelic expression of c.1568C > A at UGT2B15 is due to variation in a novel cis-regulatory element in the 3'UTR.

Chang Sun1, Catherine Southard, Olufunmilayo I Olopade, Anna Di Rienzo.   

Abstract

Differential allelic expression (DAE) is a powerful tool to identify cis-regulatory elements for gene expression. The UDP-glucuronosyltransferase 2 family, polypeptide B15 (UGT2B15), is an important enzyme involved in the metabolism of multiple endobiotics and xenobiotics. In the present study, we measured the relative expression of two alleles at SNP c.1568C>A (rs4148269) in this gene, which causes an amino acid substitution (T523K). An excess of the C over the A allele was consistently observed in both liver (P=0.0021) and breast (P=0.012) samples, suggesting that SNP(s) in strong linkage disequilibrium (LD) with c.1568C>A can regulate UGT2B15 expression in both tissues. By resequencing, one such SNP, c.1761T>C (rs3100) in 3' untranslated region (UTR), was identified. Reporter gene assays showed that the 1761T allele results in a significantly higher gene expression level than the 1761C allele in HepG2, MCF-7, LNCaP, and Caco-2 cell lines (all P<0.001), thus indicating that this variation can regulate UGT2B15 gene expression in liver, breast, colon, and prostate tissues. Considering its location, we postulated that this SNP is within an unknown microRNA binding site and can influence microRNA targeting. Considering the importance of UGT2B15 in metabolism, we proposed that this SNP might contribute to multiple cancer risk and variability in drug response.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21513781      PMCID: PMC3105206          DOI: 10.1016/j.gene.2011.04.001

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  48 in total

1.  A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep.

Authors:  Alex Clop; Fabienne Marcq; Haruko Takeda; Dimitri Pirottin; Xavier Tordoir; Bernard Bibé; Jacques Bouix; Florian Caiment; Jean-Michel Elsen; Francis Eychenne; Catherine Larzul; Elisabeth Laville; Françoise Meish; Dragan Milenkovic; James Tobin; Carole Charlier; Michel Georges
Journal:  Nat Genet       Date:  2006-06-04       Impact factor: 38.330

2.  Investigating cis-acting regulatory variation using assays of relative allelic expression.

Authors:  Nicholas J Bray; Michael C O'Donovan
Journal:  Psychiatr Genet       Date:  2006-08       Impact factor: 2.458

Review 3.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

Review 4.  microRNAs in vertebrate physiology and human disease.

Authors:  Tsung-Cheng Chang; Joshua T Mendell
Journal:  Annu Rev Genomics Hum Genet       Date:  2007       Impact factor: 8.929

Review 5.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

Review 6.  Liver-enriched transcription factors and their role in regulating UDP glucuronosyltransferase gene expression.

Authors:  D A Gardner-Stephen; P I Mackenzie
Journal:  Curr Drug Metab       Date:  2008-06       Impact factor: 3.731

7.  Allele-specific targeting of microRNAs to HLA-G and risk of asthma.

Authors:  Zheng Tan; Glenn Randall; Jihua Fan; Blanca Camoretti-Mercado; Rebecca Brockman-Schneider; Lin Pan; Julian Solway; James E Gern; Robert F Lemanske; Dan Nicolae; Carole Ober
Journal:  Am J Hum Genet       Date:  2007-08-20       Impact factor: 11.025

8.  Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure.

Authors:  A G Nackley; S A Shabalina; I E Tchivileva; K Satterfield; O Korchynskyi; S S Makarov; W Maixner; L Diatchenko
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

9.  Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines.

Authors:  Akiko Nakamura; Miki Nakajima; Hiroyuki Yamanaka; Ryoichi Fujiwara; Tsuyoshi Yokoi
Journal:  Drug Metab Dispos       Date:  2008-05-14       Impact factor: 3.922

10.  Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes.

Authors:  Jenny Jakobsson Schulze; Mattias Lorentzon; Claes Ohlsson; Jonas Lundmark; Hyung-Keun Roh; Anders Rane; Lena Ekström
Journal:  Pharmacogenet Genomics       Date:  2008-06       Impact factor: 2.089

View more
  9 in total

1.  Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancer.

Authors:  Tristan M Sissung; John Deeken; Crystal R Leibrand; Douglas K Price; Sheryl Ehrlich; Seth M Steinberg; David J Liewehr; William Dahut; William D Figg
Journal:  Pharmacogenomics       Date:  2016-11-24       Impact factor: 2.533

Review 2.  Research progress in allele-specific expression and its regulatory mechanisms.

Authors:  Uma Gaur; Kui Li; Shuqi Mei; Guisheng Liu
Journal:  J Appl Genet       Date:  2013-04-23       Impact factor: 3.240

3.  Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation.

Authors:  Kathleen G Barrett; Hailin Fang; Daniela Cukovic; Alan A Dombkowski; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2015-05-06       Impact factor: 3.922

4.  Identification of rs11615992 as a novel regulatory SNP for human P2RX7 by allele-specific expression.

Authors:  Tao Peng; Li Zhong; Jing Gao; Zhu Wan; Wei-Ping Fu; Chang Sun
Journal:  Mol Genet Genomics       Date:  2019-08-13       Impact factor: 3.291

5.  Lack of association between common UGT2B nonsynonymous single-nucleotide polymorphisms and breast cancer in populations of African ancestry.

Authors:  Chang Sun; Dezheng Huo; Barbara Nemesure; Anselm Hennis; M Cristina Leske; Suh-Yuh Wu; Qun Niu; Olufunmilayo I Olopade; Anna Di Rienzo
Journal:  Int J Cancer       Date:  2011-08-24       Impact factor: 7.396

6.  Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients.

Authors:  Natalia Sutiman; Joanne Siok Liu Lim; Thomas E Muerdter; Onkar Singh; Yin Bun Cheung; Raymond Chee Hui Ng; Yoon Sim Yap; Nan Soon Wong; Peter Cher Siang Ang; Rebecca Dent; Werner Schroth; Matthias Schwab; Chiea Chuen Khor; Balram Chowbay
Journal:  Clin Pharmacokinet       Date:  2016-10       Impact factor: 6.447

7.  The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions.

Authors:  Andrea Y Angstadt; Terryl J Hartman; Samuel M Lesko; Joshua E Muscat; Junjia Zhu; Carla J Gallagher; Philip Lazarus
Journal:  Genes Chromosomes Cancer       Date:  2014-06       Impact factor: 5.006

8.  Identification and validation of the microRNA response elements in the 3'-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach.

Authors:  Ioannis Papageorgiou; Michael H Court
Journal:  Biochem Pharmacol       Date:  2017-09-28       Impact factor: 5.858

9.  Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.

Authors:  Adriana C Vidal; Cocoa Tucker; Joellen M Schildkraut; Ricardo M Richardson; Megan McPhail; Stephen J Freedland; Cathrine Hoyo; Delores J Grant
Journal:  BMC Cancer       Date:  2013-11-22       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.